Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-17
SponsorStanford University
About this trial
This case series study seeks to evaluate the use of a Spatial Computing Device and Augmented Reality (AR) and Virtual Reality (VR) as an exposure therapy modality for children and adolescents with needle and blood-injection-injury phobia. This study will take place at Lucile Packard Children's Hospital (LPCH) and Stanford Hospital (Stanford University, Palo Alto, CA).
Eligibility criteria
Qualifiers
Patients between the ages of 11-17
Fear of needle
Patients screened with the modified APA severity Measure for Specific Phobia (blood, needles, or injections), and have an individual phobia score rated as moderate, severe, or extreme (as described below)
Disqualifiers
Legal guardian not present to obtain consent
Adolescent with a significant neurological condition, or major developmental disability
Adolescent with active infection of the face or hand
A history of severe motion sickness
Trial design
Treatments tested in this trial
- Mixed reality (XR) Exposure Therapy
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov